// App-Quantinova.ai

TCT-752 : Ecarin Clotting Time (ECT) more accurately reflects bivalirudin concentration than Activated Clotting Time (ACT) in patients undergoing Percutaneous Coronary Intervention using bivalirudin anticoagulation

Researchers

Presenter

  • Ronan Margey

Principal Investigators

  • Helen Ridgway

  • Richard Rullman

  • Jeff Spencer

  • Iris McNulty

  • Aditya Mangla

  • Sotir Polena

  • Daniel Soffer

  • Ik-Kyung Jang

Medical Centers

  • Lenox Hill Hospital, New York, NY

  • Massachusetts General Hospital, Boston, MA

  • Helena Laboratories, Beaumont, TX

  • Huntington Hospital, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Angina

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Bivalirudin

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved